Hand Arm Bimanual Intensive Therapy, bimanual therapy, occupational therapy) Two studies reported that some children experienced frustration participating in CIMT.ĬIMT versus dose‐matched comparison (e.g. There was no evidence that CIMT was more effective than a high‐dose comparison for improving unimanual capacity in a single study using QUEST (Dissociated movement MD 0.49, 95% CI −10.71 to 11.69 Grasp MD −0.20, 95% CI −11.84 to 11.44). When compared with a high‐dose comparison, CIMT was not more effective for improving bimanual performance (MD −0.39 AHA Units, 95% CI −3.14 to 2.36). individualised occupational therapy, bimanual therapy)
ERHARDT DEVELOPMENTAL PREHENSION ASSESSMENT PDF MERGE SKIN
Three studies reported adverse events, including frustration, constraint refusal and reversible skin irritations from casting.ĬIMT versus high‐dose comparison (e.g. We found low‐quality evidence that CIMT was more effective than a low‐dose comparison for improving bimanual performance (mean difference (MD) 5.44 Assisting Hand Assessment (AHA) units, 95% confidence interval (CI) 2.37 to 8.51).ĬIMT was more effective than a low‐dose comparison for improving unimanual capacity (Quality of upper extremity skills test (QUEST) ‐ Dissociated movement MD 5.95, 95% CI 2.02 to 9.87 Grasps MD 7.57, 95% CI 2.10 to 13.05 Weight bearing MD 5.92, 95% CI 2.21 to 9.6 Protective extension MD 12.54, 95% CI 8.60 to 16.47). Key results: Primary outcomes at primary endpoint (immediately after intervention)ĬIMT versus low‐dose comparison (e.g. We judged the risk of bias as moderate to high across the studies.
The most common constraint devices were a mitt/glove or a sling (11 studies each). The mean total number of hours of CIMT provided was 137 hours (range 20 to 504 hours). Duration of intervention sessions ranged from 0.5 to eight hours per day. Frequency of sessions ranged from twice weekly to seven days per week. Average length of CIMT programs was four weeks (range one to 10 weeks). Fifty‐seven outcome measures were used across studies. Mean age was 5.96 years (standard deviation (SD) 1.82), range three months to 19.8 years 53% male and 47% participants had left hemiplegia. Sample sizes ranged from 11 to 105 (mean 35). We included 36 trials (1264 participants), published between 20.
0 kommentar(er)
